Left Ventricular Dysfunction
1
Pipeline Programs
3
Companies
7
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Eko DevicesCA - Emeryville
4 programsUse of Eko DUO Electronic StethoscopeN/A1 trial
Use of Eko DUO electronic StethoscopeN/A1 trial
Use of Eko DUO electronic stethoscopeN/A1 trial
Use of Eko DUO electronic stethoscopeN/A1 trial
Active Trials
+1 more trials
Rhythm PharmaceuticalsBOSTON, MA
2 programsLeft ventricular septum pacing leadN/A1 trial
RV lead placement siteN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CordisPCI
Eko DevicesUse of Eko DUO electronic Stethoscope
Eko DevicesUse of Eko DUO electronic stethoscope
Eko DevicesUse of Eko DUO Electronic Stethoscope
Eko DevicesUse of Eko DUO electronic stethoscope
Rhythm PharmaceuticalsLeft ventricular septum pacing lead
Rhythm PharmaceuticalsRV lead placement site
Clinical Trials (7)
Total enrollment: 3,836 patients across 7 trials
Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration
Start: Feb 2006Est. completion: Oct 200820 patients
Phase 3Completed
Low Ejection Fraction in Single Lead ECG- Ochsner
Start: Aug 2021Est. completion: Apr 2022307 patients
N/ACompleted
Detection of Heart Conditions Using Artificial Intelligence
Start: Jun 2021Est. completion: Dec 202168 patients
N/ACompleted
Low Ejection Fraction in Single Lead ECG
Start: Jun 2021Est. completion: May 20221,935 patients
N/ACompleted
Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence
Start: Jul 2020Est. completion: Apr 20221,258 patients
N/ACompleted
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum
Start: Nov 2012Est. completion: Feb 2015
N/ACompleted
PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing
Start: Aug 2007Est. completion: Sep 2015248 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space